Namirotene

N/A

Report date: 2023/02/18 22:36:41

NME

Base Information

Drug NameNamirotene

Drug Alias NameCBS-211A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein biosynthesis inhibitorsRetinoic acid receptors agonistsRetinoic acid receptors binders

TargetsRetinoic acid receptors

Therapy Area/IndicationsCorneal DiseasesXerophthalmia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesChauvin

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesChauvin

Active IndicationsN/A

Inactive IndicationsCorneal DiseasesXerophthalmia

ATC CodeN/A